-
1.发明申请Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions 审中-公开组合物包括不同类型的转移因子，制备组合物的方法和使用该组合物的治疗方法公开(公告)号：US20070053919A1
公开(公告)日：2007-03-08
申请号：US11377703
申请日：2006-03-15
申请人： David Lisonbee , William Hennen , F. Daugherty
发明人： David Lisonbee , William Hennen , F. Daugherty
IPC分类号： A61K39/00
摘要： A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.
摘要翻译： 在受试者中引发T细胞介导的免疫应答的组合物包括来自至少两种不同类型的源动物的转移因子。 例如，组合物可以包括哺乳动物转移因子和非哺乳动物转移因子。 组合物的实例包括包含哺乳动物转移因子的初乳衍生产物和包含非哺乳动物转移因子的卵衍生产物的组合。 另外，卵衍生的产品可以基本上不含脂肪。 还公开了在已经用组合物处理的受试者中形成组合物并引发T细胞介导的免疫应答的方法。
-
2.发明申请COMPOSITIONS INCLUDING DIFFERENT TYPES OF TRANSFER FACTOR, METHODS FOR MAKING THE COMPOSITIONS, AND METHODS OF TREATMENT USING THE COMPOSITIONS 有权包含不同类型的转移因子的组合物，用于制备组合物的方法和使用组合物的治疗方法公开(公告)号：US20050058716A1
公开(公告)日：2005-03-17
申请号：US10663353
申请日：2003-09-15
申请人： David Lisonbee , William Hennen , F. Daugherty
发明人： David Lisonbee , William Hennen , F. Daugherty
CPC分类号： C07K14/52 , A61J3/074 , A61K35/00 , C07K14/465
摘要： A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.
摘要翻译： 在受试者中引发T细胞介导的免疫应答的组合物包括来自至少两种不同类型的源动物的转移因子。 例如，组合物可以包括哺乳动物转移因子和非哺乳动物转移因子。 组合物的实例包括包含哺乳动物转移因子的初乳衍生产物和包含非哺乳动物转移因子的卵衍生产物的组合。 另外，卵衍生的产品可以基本上不含脂肪。 还公开了在已经用组合物处理的受试者中形成组合物并引发T细胞介导的免疫应答的方法。
-
公开(公告)号：US20070071836A1
公开(公告)日：2007-03-29
申请号：US11415837
申请日：2006-05-02
IPC分类号： A61K36/889 , A61K36/87
CPC分类号： A61K36/35 , A23G4/12 , A23L2/02 , A23L2/38 , A23L2/52 , A23L2/66 , A23L33/105 , A23L33/17 , A23L33/19 , A23V2002/00 , A61K36/185 , A61K36/87 , A61K38/19 , A61K2300/00 , A23V2200/324 , A23V2250/21166
摘要： A drink includes an edible liquid or semisolid preparation and transfer factor. The drink may also include lactoferrin and one or more preservatives. An edible preparation includes a fruit component and transfer factor. The fruit component may include at least one oligoproanthocyanidin-containing fruit. The edible preparation may also include lactoferrin. One or more preservatives may also be included in the edible preparation. The drink or the edible preparation may be sterilized or pasteurized.
摘要翻译： 饮料包括可食用液体或半固体制剂和转移因子。 饮料还可以包括乳铁蛋白和一种或多种防腐剂。 可食用制剂包括水果成分和转移因子。 水果成分可以包括至少一种含有低聚花色素的水果。 可食用制剂还可包括乳铁蛋白。 一种或多种防腐剂也可以包括在可食用制剂中。 饮料或食用制剂可以灭菌或灭菌。
-
公开(公告)号：US10464980B2
公开(公告)日：2019-11-05
申请号：US11377703
申请日：2006-03-15
摘要： A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.
-
公开(公告)号：US09956258B2
公开(公告)日：2018-05-01
申请号：US11415837
申请日：2006-05-02
IPC分类号： A61K36/889 , A61K36/87 , A61K36/35 , A23G4/12 , A23L2/02 , A23L2/38 , A23L2/52 , A23L2/66 , A61K36/185 , A61K38/19 , A23L33/105 , A23L33/17 , A23L33/19
CPC分类号： A61K36/35 , A23G4/12 , A23L2/02 , A23L2/38 , A23L2/52 , A23L2/66 , A23L33/105 , A23L33/17 , A23L33/19 , A23V2002/00 , A61K36/185 , A61K36/87 , A61K38/19 , A61K2300/00 , A23V2200/324 , A23V2250/21166
摘要： A drink includes an edible liquid or semisolid preparation and transfer factor. The drink may also include lactoferrin and one or more preservatives. An edible preparation includes a fruit component and transfer factor. The fruit component may include at least one oligoproanthocyanidin-containing fruit. The edible preparation may also include lactoferrin. One or more preservatives may also be included in the edible preparation. The drink or the edible preparation may be sterilized or pasteurized.
-
6.发明申请NANOFRACTION IMMUNE MODULATORS, PREPARATIONS AND COMPOSITIONS INCLUDING THE SAME, AND ASSOCIATED METHODS 审中-公开纳米抗体免疫调节剂，包括其的制备和组合物及相关方法公开(公告)号：US20080081076A1
公开(公告)日：2008-04-03
申请号：US11855944
申请日：2007-09-14
CPC分类号： A61K35/20 , A23L33/10 , A23L33/17 , A61K35/57 , G01N33/505 , G01N2333/70514 , A61K2300/00
摘要： Compositions that include extracts from sources of immune modulators that include nanofraction immune modulator molecules (i.e., molecules having molecular weights of about 3,000 Da and less) are disclosed. These compositions may also include other immune modulators, such as transfer factor. Administration of compositions with extracts that include nanofraction immune modulator molecules modulates the cell-mediated immunity (e.g., down-regulates undesired T cell activity) of a subject to which such compositions are administered. When administered with transfer factor, the combination of nanofraction immune modulator molecules and transfer factor down-regulates undesired T cell activity while increasing, or up-regulating, T cell activity against pathogens and other undesirable entities, such as cancer cells and other aberrant or mutated cells. Assays and assay techniques for evaluating the immune modulation capabilities of various substances are also disclosed.
摘要翻译： 公开了包括来自包括纳米免疫调节剂分子（即具有约3,000Da及更小分子量的分子）的免疫调节剂来源的提取物的组合物。 这些组合物还可以包括其它免疫调节剂，例如转移因子。 具有包含纳米免疫调节分子的提取物的组合物的给药调节施用这些组合物的受试者的细胞介导的免疫（例如下调不期望的T细胞活性）。 当用转移因子施用时，纳米免疫调节剂分子和转移因子的组合下调不期望的T细胞活性，同时增加或上调T细胞活性，以抵抗病原体和其他不期望的实体，例如癌细胞和其他异常或突变 细胞。 还公开了用于评估各种物质的免疫调节能力的测定和测定技术。
-
7.发明授权Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions 有权组合物包括不同类型的转移因子，制备组合物的方法和使用该组合物的治疗方法公开(公告)号：US06866868B1
公开(公告)日：2005-03-15
申请号：US10663353
申请日：2003-09-15
CPC分类号： C07K14/52 , A61J3/074 , A61K35/00 , C07K14/465
摘要： A composition for eliciting a T-cell mediated immune response in a subject includes transfer factor from at least two different types of source animals. For example, the composition may include mammalian transfer factor and nonmammalian transfer factor. An example of the composition includes a combination of a colostrum-derived product, which includes the mammalian transfer factor, and an egg-derived product, which includes the nonmammalian transfer factor. Additionally, the egg-derived product may be substantially free of fat. Methods for forming the composition and eliciting T-cell mediated immune responses in subjects that have been treated with the composition are also disclosed.
摘要翻译： 在受试者中引发T细胞介导的免疫应答的组合物包括来自至少两种不同类型的源动物的转移因子。 例如，组合物可以包括哺乳动物转移因子和非哺乳动物转移因子。 组合物的实例包括包含哺乳动物转移因子的初乳衍生产物和包含非哺乳动物转移因子的卵衍生产物的组合。 另外，卵衍生的产品可以基本上不含脂肪。 还公开了在已经用组合物处理的受试者中形成组合物并引发T细胞介导的免疫应答的方法。
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.016 秒)
